HMG 75iu
Price range: $40.00 through $320.00
HMG is a peptide hormone preparation studied for its role in reproductive endocrinology and gonadal function. It contains both follicle-stimulating hormone (FSH) and luteinizing hormone (LH) activity, making it a valuable research tool in fertility and endocrine signaling studies.
In laboratory research, HMG has been investigated for its effects on ovarian follicle development, spermatogenesis, and the regulation of reproductive hormone pathways. It is primarily considered in experimental models exploring fertility mechanisms and endocrine balance.
Studied for combined FSH and LH activity in reproductive pathways
Investigated for effects on ovarian follicle maturation and ovulation
Explored for influence on spermatogenesis and male reproductive health
Considered in preclinical models of fertility and hormone regulation
Related products
AOD9604 10mg
AOD9604 is a synthetic peptide fragment derived from the C-terminal of human growth hormone, studied for its potential role in fat metabolism and energy regulation.
In research contexts, AOD9604 has been investigated for its effects on lipid mobilization and metabolic pathways without influencing blood sugar or growth factors. It is primarily considered in studies exploring body composition, fat oxidation, and energy balance.
Studied for roles in lipid metabolism and fat breakdown pathways
Investigated for potential influence on energy expenditure
Explored for effects on body composition and adipose tissue regulation
Considered in preclinical models of metabolic and weight-related research
Cagrilintide 5mg
Cagrilintide is a synthetic peptide studied for its potential effects on appetite regulation, body weight management, and metabolic health. It acts as an amylin analog in research settings, influencing satiety and energy balance pathways.
In experimental studies, Cagrilintide has been investigated for its influence on food intake, body composition, and glycemic control. It is commonly considered in preclinical models exploring obesity, metabolic regulation, and endocrine signaling.
Studied for effects on appetite suppression and satiety pathways
Investigated for influence on body weight and energy balance
Explored for potential impact on glycemic control and metabolism
Considered in preclinical models of cardiometabolic and metabolic research
Retatrutide 10mg
Retatrutide is a synthetic peptide under investigation for its potential effects on metabolic regulation, body weight management, and glycemic control. It acts as a multi-receptor agonist targeting GIP, GLP-1, and glucagon receptors in research settings.
In experimental studies, Retatrutide has been explored for its influence on appetite suppression, energy expenditure, and fat distribution. It is commonly considered in preclinical models studying obesity, metabolic health, and endocrine signaling.
Studied for effects on glycemic control and insulin sensitivity
Investigated for influence on appetite regulation and satiety pathways
Explored for potential impact on body weight and fat distribution
Considered in preclinical models of cardiometabolic and metabolic research
Retatrutide 20mg
Retatrutide is a synthetic peptide under investigation for its potential effects on metabolic regulation, body weight management, and glycemic control. It acts as a multi-receptor agonist targeting GIP, GLP-1, and glucagon receptors in research settings.
In experimental studies, Retatrutide has been explored for its influence on appetite suppression, energy expenditure, and fat distribution. It is commonly considered in preclinical models studying obesity, metabolic health, and endocrine signaling.
Studied for effects on glycemic control and insulin sensitivity
Investigated for influence on appetite regulation and satiety pathways
Explored for potential impact on body weight and fat distribution
Considered in preclinical models of cardiometabolic and metabolic research
Retatrutide 30mg
Retatrutide is a synthetic peptide under investigation for its potential effects on metabolic regulation, body weight management, and glycemic control. It acts as a multi-receptor agonist targeting GIP, GLP-1, and glucagon receptors in research settings.
In experimental studies, Retatrutide has been explored for its influence on appetite suppression, energy expenditure, and fat distribution. It is commonly considered in preclinical models studying obesity, metabolic health, and endocrine signaling.
Studied for effects on glycemic control and insulin sensitivity
Investigated for influence on appetite regulation and satiety pathways
Explored for potential impact on body weight and fat distribution
Considered in preclinical models of cardiometabolic and metabolic research
Semaglutide 10mg
Semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist studied for its potential effects on glucose regulation, appetite control, and metabolic health.
In experimental studies, Semaglutide has been investigated for its influence on insulin secretion, satiety pathways, and body weight management. It is commonly considered in preclinical models exploring endocrine signaling, diabetes, and obesity-related research.
Studied for effects on insulin secretion and glycemic control
Investigated for influence on appetite regulation and satiety pathways
Explored for potential impact on body weight and metabolic health
Considered in preclinical models of endocrine and cardiometabolic research
Semaglutide 5mg
Semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist studied for its potential effects on glucose regulation, appetite control, and metabolic health.
In experimental studies, Semaglutide has been investigated for its influence on insulin secretion, satiety pathways, and body weight management. It is commonly considered in preclinical models exploring endocrine signaling, diabetes, and obesity-related research.
Studied for effects on insulin secretion and glycemic control
Investigated for influence on appetite regulation and satiety pathways
Explored for potential impact on body weight and metabolic health
Considered in preclinical models of endocrine and cardiometabolic research
Tirzepatide 15mg
Tirzepatide is a synthetic peptide studied for its dual action as a GIP and GLP-1 receptor agonist, with potential effects on glucose regulation, metabolism, and weight management.
In experimental studies, Tirzepatide has been investigated for its influence on insulin sensitivity, appetite regulation, and body composition. It is commonly considered in preclinical models exploring endocrine signaling, cardiometabolic health, and obesity-related pathways.
Studied for effects on insulin sensitivity and glycemic control
Investigated for influence on appetite regulation and satiety pathways
Explored for potential impact on body weight and fat distribution
Considered in preclinical models of cardiometabolic and metabolic health
Reviews
There are no reviews yet.